Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 2, 2013, Pages 376-383

  Gasparetto, Valeria ^a   Fraccaro, Chiara ^a   Tarantini, Giuseppe ^a   Buja, Paolo ^a   D'Onofrio, Augusto ^a   Yzeiraj, Ermela ^a   Pittarello, Demetrio ^a   Isabella, Giambattista ^a   Gerosa, Gino ^a   Iliceto, Sabino ^a   Napodano, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

aortic valve stenosis; coronary artery disease; transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; ECHOCARDIOGRAPHY; EUROSCORE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; SAFETY; SURGICAL APPROACH; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; CORONARY STENOSIS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874489259     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24434     Document Type: Article

References (18)

1. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, Kraft KD, Miyake-Hull CY, Schwaegler RG,. Prospective study of asymptomatic valvular aortic stenosis: Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95: 2262-2270.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS,. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-e661.
3. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A,. Task force on the management of valvular heart disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
4. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Piérard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T,. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29: 1463-1470.
5. Dewey MT, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, Svensson LG, Tuzcu M, Webb JC, Cribier A, Mack MJ,. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010; 89: 758-767.
6. Masson JB, Lee M, Boone RH, Al Ali A, Al Bugami S, Hamburger J, Mancini JB, Ye J, Cheung A, Humphries KH, Wood D, Nietlispach F, Webb JG,. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 165-173.
7. Gautier M, Pepin M, Himbert D, Ducrocq G, Iung B, Dilly MP, Attias D, Nataf P, Vahanian A,. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 2011; 7: 549-555.
8. Wenaweser P, Pilgrim T, Guerios E, Stortecky S, Huber C, Khattab AA, Kadner A, Buellesfeld L, Gloekler S, Meier B, Carrel T, Windecker S,. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2011; 7: 541-548.
9. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller CM, le Morel M, Petersen J, Popma JJ, Takkenberg JJM, Vahanian A, van Es GA, Vranckx P, Webb JC, Windecker S, Serruys PW,. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. Eur Heart J 2011; 32: 205-217.
10. Ong AT, Serruys PW,. Complete revascularization: Coronary artery bypass graft surgery versus percutaneous coronary interventions. Circulation 2006; 114: 249-255.
11. Piazza N, Grube E, Gerkens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW,. Procedural and 30-day outcome following transcatheter aortic valve implantation using the third generation (18Fr) CoreValve Revalving System: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
12. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V,. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.
13. Otten A, Van Domburg R, Van Gameren M, Kappetein AP, Takkenberg J, Bogers A, Serruys PW, De Jaegere P,. Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention 2008; 4: 250-255.
14. Ashikhmina EA, Schaff HV, Dearani JA, Sundt III TM, Suri RM, Park SJ, Burkhart HM, Li Z, Daly RC,. Aortic valve replacement in the elderly. Determinants of late outcome. Circulation 2011; 124: 1070-1078.
15. Di Eusanio M, Fortuna D, De Palma R, Dell'Amore A, Lamarra M, Contini GA, Gherli T, Gabbieri D, Ghidoni I, Cristell D, Zussa C, Pigini F, Pugliese P, Pacini D, Di Bartolomeo R,. Aortic valve replacement: Results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg 2010; 141: 940-947.
16. Florath I, Rosendahl UP, Mortasawi A, Bauer SF, Dalladaku F, Ennker IC, Ennker JC,. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann Thorac Surg 2003; 76: 75-83.
17. Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T, Reichenspurner H, Treede H,. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 2011; 100: 311-316.
18. Geist V, Sherif MA, Khattab AA,. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. Catheter Cardiovasc Interv 2009; 73: 61-67.